#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extraskeletal ossification Amyloidosis Neuroendocrine tumour of the lung Myxoid liposarcoma Hypereosinophilic syndrome Optic glioma Kawasaki's disease Prodromal Alzheimer's disease Metabolic disorder Erdheim-Chester disease Leiomyosarcoma metastatic Meningitis meningococcal Philadelphia positive chronic myeloid leukaemia Extra-osseous Ewing's sarcoma Small cell lung cancer recurrent More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Niemann-Pick disease – Treatment Pleural mesothelioma malignant – Basic Information Alveolar rhabdomyosarcoma Pelizaeus-Merzbacher disease – Life with Disease Pemphigoid – Life with Disease Antithrombin III deficiency – Trials in Disease Hereditary angioedema – Diagnostics Medulloblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Siponimod RO7268489 Vsf1.01 Vismodegib Ranitidine Poa Pratensis LTX-002 SODIUM Amy109 Histamine Dihydrochloride Pitolisant Levodopa Kbp-336 Palmidrol Avapritinib Methylprednisolone Timolol Gindameran Relugolix Enpatoran SC0062 More therapies…

    Learn about Your Condition

    Systemic lupus erythematosus Intervertebral disc protrusion Short-bowel syndrome Latent tuberculosis Chronic hepatic failure Bile acid synthesis disorder Thalassaemia beta Lupus nephritis Hyperparathyroidism secondary Drug eruption Bronchopulmonary aspergillosis Immune system disorder Breast cancer stage IV Papillary thyroid cancer Pancreaticoduodenectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Reducing Antibiotic Duration for Pneumonia in Children Using Amoxicillin

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin Trihydrate
    France

  • Comparing Pain Relief Methods in Colorectal Cancer Surgery: TAP Block vs. Port Site Infiltration with Levobupivacaine for Patients in ERAS Program

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Levobupivacaine
    Spain

  • Study on Fibrinogen Replacement to Prevent Brain Bleeding in Stroke Patients After Thrombolysis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Fibrinogen
    Italy

  • Study on Severe Erythema Multiforme: Comparing Methylprednisolone Acetate and Lidocaine Hydrochloride Monohydrate with Placebo for Hospitalized Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Erythema multiforme
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    • Prednisone
    France

  • Study on L-Glutamic Acid and Sodium Chloride to Prevent Acute Kidney Injury in High-Risk Heart Surgery Patients Without Diabetes

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute kidney injury
    Investigated Drugs:
    • L-Glutamic Acid
    • Sodium Chloride
    Sweden

  • Study of Propranolol and Vinorelbine for Children and Teenagers with Refractory or Relapsing Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant glioma
    • Desmoid tumour
    • Neoplasm malignant
    Investigated Drugs:
    • Propranolol Hydrochloride
    • Vinorelbine Tartrate
    France
Previous Page
1 … 837 838 839 840 841 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!